Assignee profile:

Alkahest, Inc.

City:

San Carlos, California

Country:

United States

Published Applications:

26

Last publication date:

2024-08-01

Patent Grants:

26

Last grant date:

2025-12-16

Top Inventors for applications by Alkahest, Inc.

These are the the leading inventors for applications assigned to Alkahest, Inc.:

Recent patent applications by Alkahest, Inc.

Alkahest, Inc. based in San Carlos, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2024-08-01 ✅ Patent 12,496,296 granted on 2025-12-16
US20240252478A1
Human necessities

Benzodioxane Modulators of Leukotriene A4 Hydrolase (LTA4H) for Prevention and Treatment of Aging-Associated Diseases

#2 | 2024-01-25 ✅ Patent 11,951,102 granted on 2024-04-09
US20240024305A1
Human necessities

Methods and compositions for treating retina-associated disease using CCR3-inhibitors

#3 | 2023-05-11 ✅ Patent 11,957,671 granted on 2024-04-16
US20230146135A1
Human necessities

Benzodioxane modulators of leukotriene A4 hydrolase (LTA4H) for prevention and treatment of aging-associated diseases

#4 | 2023-01-26 ✅ Patent 12,053,489 granted on 2024-08-06
US20230026763A1
Human necessities

Blood plasma fractions for use in liver regeneration

#5 | 2022-11-24 ✅ Patent 12,059,453 granted on 2024-08-13
US20220370568A1
Human necessities

Blood plasma fractions for use in muscle regeneration

#6 | 2021-09-02 ✅ Patent 11,484,551 granted on 2022-11-01
US20210268021A1
Human necessities

Method of treating liver failure with plasma fraction IV-4

#7 | 2021-05-20 ✅ Patent 11,660,316 granted on 2023-05-30
US20210145875A1
Human necessities

Methods of inducing liver regeneration by administering a plasma protein fraction

#8 | 2021-05-06 ✅ Patent 11,439,687 granted on 2022-09-13
US20210128693A1
Human necessities

Blood plasma fractions for use in muscle regeneration

#9 | 2021-04-15 ✅ Patent 11,547,724 granted on 2023-01-10
US20210106616A1
Human necessities

Methods of treating a subject for pain

#10 | 2021-04-15 ✅ Patent 11,590,118 granted on 2023-02-28
US20210106577A1
Human necessities

Methods and compositions for treating retina-associated disease using CCR3-inhibitors

#11 | 2021-03-04 ✅ Patent 11,413,308 granted on 2022-08-16
US20210060063A1
Human necessities

Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products

#12 | 2020-11-26 ✅ Patent 11,344,542 granted on 2022-05-31
US20200368220A1
Human necessities

Treatment of aging-associated disease with modulators of leukotriene Ahydrolase

#13 | 2020-08-13 ✅ Patent 11,612,596 granted on 2023-03-28
US20200253950A1
Human necessities

Pharmaceutical formulations comprising CCR3 antagonists

#14 | 2020-04-30 ✅ Patent 11,298,377 granted on 2022-04-12
US20200129550A1
Human necessities

Methods of improving wound healing

#15 | 2020-04-30 ✅ Patent 11,103,530 granted on 2021-08-31
US20200129549A1
Human necessities

Methods of improving or accelerating postoperative recovery

#16 | 2019-11-21 ✅ Patent 11,426,399 granted on 2022-08-30
US20190350917A1
Human necessities

Treatment of aging-associated disease with modulators of leukotriene A4 hydrolase

#17 | 2019-10-31 ✅ Patent 11,040,068 granted on 2021-06-22
US20190328782A1
Human necessities

Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products

#18 | 2019-09-19 ✅ Patent 10,874,692 granted on 2020-12-29
US20190282617A1
Human necessities

Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products

#19 | 2019-06-06 ✅ Patent 10,905,717 granted on 2021-02-02
US20190167719A1
Human necessities

Blood plasma and plasma fractions as therapy for tumor growth and progression

#20 | 2019-04-11 ✅ Patent 11,382,907 granted on 2022-07-12
US20190105314A1
Human necessities

Methods and compositions for treating aging-associated impairments using CCR3-inhibitors

#21 | 2018-11-01 ✅ Patent 10,357,513 granted on 2019-07-23
US20180311280A1
Human necessities

Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products

#22 | 2018-10-18 ✅ Patent 10,487,148 granted on 2019-11-26
US20180298102A1
Chemistry; metallurgy

Methods and compositions for treating aging-associated impairments

#23 | 2018-04-26 ✅ Patent 10,525,107 granted on 2020-01-07
US20180110839A1
Human necessities

Blood plasma fractions as a treatment for aging-associated cognitive disorders

#24 | 2017-11-30 ✅ Patent 10,245,285 granted on 2019-04-02
US20170340671A1
Human necessities

Blood plasma and plasma fractions as therapy for tumor growth and progression

#25 | 2017-08-17 ✅ Patent 10,905,779 granted on 2021-02-02
US20170232118A1
Human necessities

Methods for screening human blood products comprising plasma using immunocompromised rodent models

#26 | 2013-10-10 ✅ Patent 10,213,421 granted on 2019-02-26
US20130266646A1
Human necessities

Pharmaceutical formulations comprising CCR3 antagonists

Also check out Alkahest, Inc.'s (San Carlos, United States) applicant profile with 29 patent applications submitted.

AssigneeID:

354741 ⎘